.webp)
Rotavirus infections are one of the leading causes of gastroenteritis in infants and young children worldwide, particularly in areas with limited access to clean water and healthcare. This virus causes severe diarrhoea, vomiting, and fever. Before the development of the rotavirus vaccine, nearly all children contracted the virus before their fifth birthday. While most cases can be managed at home with careful rehydration, severe dehydration can occur, potentially requiring hospitalisation for intravenous fluids.
The rotavirus vaccine offers several key benefits that help reduce the impact of rotavirus infections on children and families.
The primary benefit of the rotavirus vaccine is the prevention of severe gastrointestinal illness caused by rotavirus. This includes reducing the risk of dehydration, which can be life-threatening, especially in infants and young children. Children who receive the vaccine are far less likely to experience the severe symptoms of rotavirus infection, which often require hospitalisation.
Studies have shown that rotavirus vaccination significantly decreases the number of hospitalisations due to severe diarrhoea and dehydration. This not only helps protect the child but also reduces the burden on healthcare systems, allowing resources to be directed toward other medical needs.
Rotavirus infections can lead to severe dehydration and, in rare cases, death. The vaccine has been proven to reduce rotavirus-related deaths, particularly in areas with high rates of infection and limited access to medical care. In low-resource settings, the vaccine is particularly effective in preventing fatalities from rotavirus-related complications.
The vaccination of large populations also helps reduce the spread of the virus within communities. When a significant portion of the population is vaccinated, even those who cannot be vaccinated (such as those with specific medical conditions) are indirectly protected, contributing to a reduction in the overall incidence of rotavirus infections.
The rotavirus vaccine is considered safe for most children. Like all vaccines, the rotavirus vaccine can cause side effects, but the vast majority of these are mild and temporary. Common side effects include mild diarrhoea or irritability following vaccination. Serious side effects, such as severe allergic reactions, are extremely rare.
Extensive studies have been conducted to assess the safety and efficacy of the rotavirus vaccine. According to the CDC and the WHO, both the RotaTeq (three-dose series) and Rotarix (two-dose series) vaccines have undergone rigorous clinical trials, which demonstrated their safety and effectiveness in preventing rotavirus infections. These vaccines have been shown to have a very high efficacy rate, typically above 85%, in preventing severe rotavirus disease.
The vaccine is continuously monitored for safety after approval. Surveillance systems in many countries track any adverse events following vaccination, and the vaccines have consistently shown a favourable safety profile. It is important to note that, in very rare cases, the vaccine has been linked to an increased risk of a condition called intussusception, which is a type of bowel obstruction. However, the risk is very low, and the benefits of vaccination far outweigh this risk. Parents and healthcare providers are encouraged to discuss any concerns with a healthcare professional before vaccination.
The rotavirus vaccine prevents rotavirus infections by stimulating the body’s immune system to produce antibodies against the virus. These antibodies help the body fight off the infection if the child is exposed to the virus in the future.
The rotavirus vaccine is unique in that it is given orally rather than by injection. The vaccine contains live, weakened rotavirus strains, which stimulate the immune system to recognise and fight the virus without causing illness. After vaccination, the immune system is "primed" to recognise the rotavirus and respond more quickly and effectively if the child is later exposed to the virus.
Once ingested, the weakened rotavirus strains in the vaccine interact with the immune cells in the intestines. This interaction triggers the production of antibodies that recognise the virus and prevent it from causing illness. If a vaccinated child is later exposed to rotavirus, their immune system is able to respond rapidly, preventing the virus from replicating and causing severe illness. In addition to the initial immune response, the vaccine also induces long-lasting immunity, which reduces the likelihood of infection or severe disease.
The rotavirus vaccine has been proven to be highly effective in preventing severe rotavirus infections, which can lead to dehydration, hospitalisation, and sometimes death. In areas where rotavirus vaccination has been widely implemented, there has been a marked decline in both the incidence of rotavirus infections and the severity of the disease.
The rotavirus vaccine is an essential tool in preventing severe rotavirus infections in infants and young children. It is safe, effective, and crucial in reducing hospitalisations and deaths associated with rotavirus infections. By providing immunity against this highly contagious virus, the vaccine helps protect individual children and contributes to the broader public health effort to prevent outbreaks and ensure healthy communities.
For expert advice on the rotavirus vaccine, visit Pantai Hospital or you can also book an appointment via our website or download the MyHealth360 application from Google Play Store or Apple App Store.
Pantai Hospitals have been accredited by the Malaysian Society for Quality in Health (MSQH) for its commitment to patient safety and service quality.
1.Immunization, Vaccines and Biologicals. (n.d.). Immunization, Vaccines and Biologicals. Retrieved January 24, 2025, from https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/rotavirus
2.Rotavirus Vaccination: For Providers. (n.d.). CDC. Retrieved January 24, 2025, from https://www.cdc.gov/vaccines/vpd/rotavirus/hcp/index.html
3.Rotavirus Vaccination | Rotavirus. (2024, July 19). CDC. Retrieved January 24, 2025, from https://www.cdc.gov/rotavirus/vaccines/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fvpd%2Frotavirus%2Fpublic%2Findex.html
.webp?sfvrsn=20763f7d_21)
.webp?sfvrsn=f2a2c343_12)
e-Shop
Request an Appointment.webp?sfvrsn=276ce14_1/vector-(3).webp)
International Patient
Find A Doctor
